The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 11, 2018

Filed:

Dec. 17, 2015
Applicant:

Artventive Medical Group, Inc., San Marcos, CA (US);

Inventor:

Leon Rudakov, San Marcos, CA (US);

Assignee:

ArtVentive Medical Group, Inc., San Marcos, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 37/00 (2006.01); A61M 31/00 (2006.01); A61B 17/12 (2006.01); A61N 5/10 (2006.01); A61M 39/22 (2006.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61M 31/007 (2013.01); A61B 17/1204 (2013.01); A61B 17/1215 (2013.01); A61B 17/12109 (2013.01); A61B 17/12172 (2013.01); A61B 17/12177 (2013.01); A61B 17/12186 (2013.01); A61M 39/22 (2013.01); A61N 5/1002 (2013.01); A61B 17/1214 (2013.01); A61B 2017/00893 (2013.01); A61B 2017/12054 (2013.01); A61M 2202/0208 (2013.01); A61M 2205/04 (2013.01); A61M 2205/052 (2013.01); A61N 2005/1003 (2013.01);
Abstract

A method for treating a subject diagnosed with a cancer or other disorder comprising a hyperproliferative tissue is described herein. The method includes localized delivery of a material which contains a therapeutically effective agent and/or moiety. The localized delivery of the agent is achieved using a catheter-based delivery system and an implant. An implant can include a support component, a cover component, and a valve component. The valve component can be operable to permit flow through the implant. The implant can be delivered on a catheter, with one of the ends of the implant being selectively expanded to permit temporary occlusion of a vessel while delivering a material through the valve component to a downstream target region. The other end of the implant can thereafter be released such that the implant occludes the vessel, or the implant can be removed from the vessel entirely.


Find Patent Forward Citations

Loading…